Advertisement

Topics

Mavyret approved for hepatitis C

10:50 EDT 4 Aug 2017 | Medical Xpress

(HealthDay) —Mavyret (glecaprevir and pibrentasvir) has been approved by the U.S. Food and Drug Administration to treat adults with certain types of chronic hepatitis C virus (HCV).

Original Article: Mavyret approved for hepatitis C

NEXT ARTICLE

More From BioPortfolio on "Mavyret approved for hepatitis C"

Quick Search
Advertisement
 

Relevant Topic

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...